SIMCERE PHARMA(02096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02096 SIMCERE PHARMA

Market Closed 04-02 16:08:21

13.620

+0.100

+0.74%

High13.730	Low13.030	Vol11.25M
Open13.530	D1 Closing13.520	Amplitude5.18%
Mkt Cap35.36B	Tradable Cap35.36B	Total Shares2.60B
T/O150.81M	T/O Rate0.43%	Tradable Shares2.60B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02096","market":"HK","secType":"STK","nameCN":"SIMCERE PHARMA","latestPrice":13.62,"timestamp":1775117301004,"preClose":13.52,"halted":0,"volume":11249745,"delay":0,"changeRate":0.007396449704141985,"floatShares":2596000000,"shares":2596000000,"eps":0.6142696805342195,"marketStatus":"Market Closed","change":0.1,"latestTime":"04-02 16:08:21","open":13.53,"high":13.73,"low":13.03,"amount":150806522,"amplitude":0.051775,"askPrice":13.62,"askSize":120000,"bidPrice":13.61,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.6142696805342195,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":7,"adr":0,"listingDate":1603728000000,"exchange":"SEHK","adjPreClose":13.52,"dividendRate":0.014947,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":1.31133503600921,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02096/tweets","defaultTab":"tweets","newsList":[{"id":"1167490074","title":"SIMCERE PHARMA Keeps Share Base Steady in March 2026; Public Float Above 15.45% Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=1167490074","media":"Bulletin Express","labels":["SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167490074?lang=en_us&edition=fundamental","pubTime":"2026-04-02 16:43","pubTimestamp":1775119434,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited (SIMCERE PHARMA) filed its Monthly Return for the period ended 31 March 2026, showing that the company’s equity structure remained unchanged during the month....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179284831","title":"Bocom International Raises SIMCERE PHARMA (02096) Target Price to HK$17.7, Keeps \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1179284831","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179284831?lang=en_us&edition=fundamental","pubTime":"2026-03-30 16:48","pubTimestamp":1774860504,"startTime":"0","endTime":"0","summary":"Bocom International has released a research report announcing an increase in the target price for SIMCERE PHARMA (02096) to HK$17.7, while maintaining a \"Buy\" rating and highlighting the stock as a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623080313","title":"Assessing Simcere Pharmaceutical Group’s Valuation After Strong Earnings And Positive SIM0237 Cancer Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2623080313","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623080313?lang=en_us&edition=fundamental","pubTime":"2026-03-30 15:06","pubTimestamp":1774854368,"startTime":"0","endTime":"0","summary":"Why Simcere’s latest earnings and cancer trial update matter for investors\nSimcere Pharmaceutical Group (SEHK:2096) has just paired strong full year 2025 earnings with encouraging Phase I/II data for its bladder cancer therapy SIM0237, a combination that is drawing fresh attention from investors.\nSee our latest analysis for Simcere Pharmaceutical Group.\nThe latest 7.96% 1 day share price return to HK$12.07, alongside a 52.80% 1 year total shareholder return and solid multi year gains, points...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/assessing-simcere-pharmaceutical-groups-valuation-after-stro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/assessing-simcere-pharmaceutical-groups-valuation-after-stro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","DCF","BK1191","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623331674","title":"Simcere Pharmaceutical Group Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2623331674","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623331674?lang=en_us&edition=fundamental","pubTime":"2026-03-29 09:21","pubTimestamp":1774747303,"startTime":"0","endTime":"0","summary":"It's been a good week for Simcere Pharmaceutical Group Limited ( HKG:2096 ) shareholders, because the company has just...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/simcere-pharmaceutical-group-limited-beat-analyst-estimates","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/simcere-pharmaceutical-group-limited-beat-analyst-estimates","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","BK1583","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147484605","title":"Stock Track | SIMCERE PHARMA Soars 7.87% in Morning Session on New CEO Appointment and Strong Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1147484605","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147484605?lang=en_us&edition=fundamental","pubTime":"2026-03-27 12:22","pubTimestamp":1774585375,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA's stock soared 7.87% during the morning trading session on Friday, reflecting strong investor confidence in the company's strategic direction.The surge follows the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102992106","title":"SIMCERE PHARMA Shares Surge Nearly 8% in Morning Session Following Appointment of Former HENGRUI PHARMA Chairman as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1102992106","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102992106?lang=en_us&edition=fundamental","pubTime":"2026-03-27 12:04","pubTimestamp":1774584261,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) saw its shares rise nearly 8% before the midday break. At the time of writing, the stock was up 7.87%, trading at HK$12.06, with a turnover of HK$45.592 million. On March 25,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","LU2580892789.USD","LU0405327494.USD","BK0183","LU1255011170.USD","BK0188","LU1820825898.SGD","BK1191","LU0359202008.SGD","LU1781817850.SGD","LU1580142542.USD","BK4585","BK0196","LU2097828474.EUR","LU2097828714.EUR","LU0359201885.HKD","LU1997245177.USD","02096","BK1583","LU1997245094.SGD","LU1997244956.HKD","LU1328615791.USD","LU2289578879.USD","LU2580892862.HKD","BK0012","LU0359201612.USD","BK0239","LU1064130708.USD","LU2543165471.USD","LU2495084118.USD","LU2097828631.EUR","LU1146622755.USD","LU2328871848.SGD","LU2097828805.USD","LU1969619763.USD","LU1023057109.AUD","VXUS","LU0405327148.USD","LU2488822045.USD","600276","LU2097828557.USD","BK4588","LU2148510915.USD","01276","BK0028","LU1655091616.SGD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622857595","title":"Simcere Pharmaceutical FY2026 RSU awards climb to 2.2 million; HKD 11.18 closing price holds on grant date","url":"https://stock-news.laohu8.com/highlight/detail?id=2622857595","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622857595?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:16","pubTimestamp":1774527396,"startTime":"0","endTime":"0","summary":"Simcere said its board approved the grant of 2,169,000 restricted share units  under its 2021 RSU Scheme to 54 employee participants.The RSUs were granted at nil purchase price, and the share closing price on the grant date was HKD 11.18.Vesting is scheduled in three equal tranches on March 26, 2027, March 26, 2028, and March 26, 2029.The awards will be satisfied using 2,169,000 shares held by trustees that relate to previously granted RSUs that lapsed.After the grant, Simcere reported 239,008,711 shares available for future grant under the scheme mandate limit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL2NkxZ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104196878","title":"SIMCERE PHARMA Invests HK$22.03 Million in Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1104196878","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104196878?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:11","pubTimestamp":1774527095,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) announced that on March 26, it repurchased 1.974 million shares at a total cost of HK$22.0324 million.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116060338","title":"Simcere Pharma Buys Back 1.97 Million Shares, Brings Cumulative Repurchases to 12.83 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1116060338","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116060338?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:05","pubTimestamp":1774526735,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited (Simcere Pharma) disclosed that it repurchased 1.97 million ordinary shares on 26 March 2026 through on-market transactions at prices ranging between HKD 10.9444...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622868743","title":"Simcere Pharmaceutical Group (SEHK:2096) Margin Rebound Challenges Long Term Earnings Skepticism","url":"https://stock-news.laohu8.com/highlight/detail?id=2622868743","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622868743?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:17","pubTimestamp":1774523837,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group (SEHK:2096) has reported its FY 2025 first half results with revenue of C¥3.6b and basic EPS of C¥0.25, setting a clear marker for how the year is shaping up. The company has seen revenue move from C¥3.1b in 1H 2024 to C¥3.5b in 2H 2024 and then to C¥3.6b in 1H 2025. Basic EPS progressed from C¥0.18 in 1H 2024 to C¥0.11 in 2H 2024 and then to C¥0.25 in the latest period, while trailing net margins sit at 17.4%, giving investors more detail on the recent...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/simcere-pharmaceutical-group-sehk2096-margin-rebound-challen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2096/simcere-pharmaceutical-group-shares/news/simcere-pharmaceutical-group-sehk2096-margin-rebound-challen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1191","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622917070","title":"BRIEF-Simcere Pharmaceutical Says Unit To Buy Entire Stake In Target Company For RMB30.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622917070","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622917070?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:27","pubTimestamp":1774452458,"startTime":"0","endTime":"0","summary":"BRIEF-Simcere Pharmaceutical Says Unit To Buy Entire Stake In Target Company For RMB30.8 MillionMarch 25  - Simcere Pharmaceutical Group Ltd 2096.HK:UNIT TO BUY ENTIRE STAKE IN TARGET COMPANY FOR RMB30.8 MILLIONTARGET CO REFERS TO SHANGHAI SIMCERE DIAGNOSTIC TECHNOLOGYFurther company coverage: 2096.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D0Y0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168248572","title":"SIMCERE PHARMA Subsidiary to Acquire Full Ownership of Shanghai Simcere Diagnostics Technology for RMB 30.76 Million, Aims to Establish Open Innovation Hub","url":"https://stock-news.laohu8.com/highlight/detail?id=1168248572","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168248572?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:17","pubTimestamp":1774451874,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) announced that on March 25, 2026, the buyer, Simcere Pharmaceutical Co., Ltd. (an indirect wholly-owned subsidiary of the company), entered into an equity transfer agreement...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164334804","title":"SIMCERE PHARMA Reports Record Revenue of 7.73 Billion Yuan for 2025, with Innovative Drug Sales Rising","url":"https://stock-news.laohu8.com/highlight/detail?id=1164334804","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164334804?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:10","pubTimestamp":1774451424,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) announced its 2025 financial results, achieving revenue of 7.731 billion yuan, representing a 16.5% year-on-year increase. Revenue from innovative drug operations reached 6.304...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1191","06978","02096","159992","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126268311","title":"SIMCERE PHARMA Announces Appointment of Co-Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1126268311","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126268311?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:10","pubTimestamp":1774451417,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) announced that Ms. Huang Huiling has resigned as a co-company secretary of the company, effective March 25, 2026. Ms. Mai Baowen has been appointed as a co-company secretary,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02096","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160973805","title":"SIMCERE PHARMA Announces Dr. Zhou Yunshu as New CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1160973805","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160973805?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:06","pubTimestamp":1774451178,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) has announced the appointment of Dr. Zhou Yunshu as Chief Executive Officer, effective March 25, 2026. In this role, Dr. Zhou, as a senior management member, will be...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","LU2495084118.USD","LU0405327494.USD","BK0239","LU2097828714.EUR","LU1997245177.USD","LU1328615791.USD","BK0196","LU1997245094.SGD","BK1191","LU1820825898.SGD","BK0183","LU2097828631.EUR","LU2488822045.USD","LU1781817850.SGD","LU1997244956.HKD","LU0405327148.USD","LU1146622755.USD","LU2097828805.USD","BK0012","02096","BK0188","BK1583","LU2148510915.USD","LU2580892789.USD","LU2097828557.USD","LU1655091616.SGD","LU2097828474.EUR","LU1064130708.USD","LU2328871848.SGD","600276","BK0060","LU1255011170.USD","LU1580142542.USD","LU2289578879.USD","LU1969619763.USD","LU2580892862.HKD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188001274","title":"Simcere Pharma names industry veteran Zhou Yunshu as Chief Executive Officer; Chairman Ren Jinsheng steps down from CEO role","url":"https://stock-news.laohu8.com/highlight/detail?id=1188001274","media":"Bulletin Express","labels":["executive","SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188001274?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:05","pubTimestamp":1774451113,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited (Simcere Pharma, 02096) has appointed Dr. Zhou Yunshu as Chief Executive Officer effective 25 March 2026, according to a board announcement released in Hong Kong....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133490217","title":"Simcere Pharma Plans Article Overhaul to Support Virtual AGMs and Treasury-Share Regime","url":"https://stock-news.laohu8.com/highlight/detail?id=1133490217","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133490217?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:02","pubTimestamp":1774450920,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited (Simcere Pharma) announced plans to revise its existing Articles of Association to strengthen shareholder protections and introduce greater corporate flexibility....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146776701","title":"SIMCERE PHARMA appoints Cherie Mak as Joint Company Secretary following Wai Ling Wong’s resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=1146776701","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146776701?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:01","pubTimestamp":1774450895,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited (SIMCERE PHARMA) announced a change in its company secretarial team, effective 25 March 2026. Wai Ling Wong has resigned as Joint Company Secretary after...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168474765","title":"Simcere Pharma Announces RMB0.18 Final Dividend for FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1168474765","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168474765?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:01","pubTimestamp":1774450875,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited (Simcere Pharma) declared a final ordinary dividend of RMB0.18 per share for the financial year ended 31 December 2025, according to the announcement released on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622077544","title":"Simcere Pharmaceutical appoints Cherie Mak as joint company secretary; Wong Wai Ling resigns effective March 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622077544","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622077544?lang=en_us&edition=fundamental","pubTime":"2026-03-25 22:53","pubTimestamp":1774450411,"startTime":"0","endTime":"0","summary":"Simcere said joint company secretary Wai Ling Wong resigned effective March 25, 2026.Cherie Mak Po Man was appointed joint company secretary effective March 25, 2026, and she is vice president of SWCS Corporate Services Group .Mak has over 20 years of experience across audit, accounting, corporate finance, compliance, and corporate secretarial work.Yushan Wan will remain as the other joint company secretary and is also Simcere’s CFO and an executive director.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 25, 2026, and is solely responsible for the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL67BHHD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02096","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.simcere.com","stockEarnings":[{"period":"1week","weight":0.2182},{"period":"1month","weight":0.1782},{"period":"3month","weight":0.1542},{"period":"6month","weight":0.0334},{"period":"1year","weight":0.6483},{"period":"ytd","weight":0.1378}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.093182},{"month":2,"riseRate":0.666667,"avgChangeRate":0.070781},{"month":3,"riseRate":0.5,"avgChangeRate":-0.014071},{"month":4,"riseRate":0.666667,"avgChangeRate":0.01967},{"month":5,"riseRate":0.8,"avgChangeRate":0.158743},{"month":6,"riseRate":0.6,"avgChangeRate":0.036684},{"month":7,"riseRate":0.2,"avgChangeRate":-0.0521},{"month":8,"riseRate":0.4,"avgChangeRate":-0.05132},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0324},{"month":10,"riseRate":0.8,"avgChangeRate":0.108781},{"month":11,"riseRate":0.666667,"avgChangeRate":0.044275},{"month":12,"riseRate":0.5,"avgChangeRate":0.000552}],"exchange":"SEHK","name":"SIMCERE PHARMA","nameEN":"SIMCERE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SIMCERE PHARMA(02096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SIMCERE PHARMA(02096) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SIMCERE PHARMA,02096,SIMCERE PHARMA股票,SIMCERE PHARMA股票老虎,SIMCERE PHARMA股票老虎国际,SIMCERE PHARMA行情,SIMCERE PHARMA股票行情,SIMCERE PHARMA股价,SIMCERE PHARMA股市,SIMCERE PHARMA股票价格,SIMCERE PHARMA股票交易,SIMCERE PHARMA股票购买,SIMCERE PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SIMCERE PHARMA(02096),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SIMCERE PHARMA(02096) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}